Literature DB >> 10873567

Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains.

L Xu1, Y Shen, T Joseph, A Bryant, J Q Luo, P Frankel, T Rotunda, D A Foster.   

Abstract

Phospholipase D (PLD) activity is elevated in response to the oncogenic stimulus of several signaling oncogenes. PLD activity is also elevated in response to peptide growth factors, indicating that PLD likely plays an important role in mitogenic signaling. Many proteins that mediate mitogenic signaling are localized in caveolin-enriched membrane microdomains (CEMMs). We report here that the elevated PLD activity in NIH 3T3 cells transformed by activated oncogenic forms of Src, Ras, and Raf is largely restricted to the CEMMs. Likewise, the PLD activity stimulated by epidermal growth factor is also restricted to the CEMMs. Although both PLD1 and PLD2 were found in CEMMs, neither was particularly enriched in the CEMMs of the transformed relative to the parental cells, indicating that it is the specific activity of PLD that is increased in the CEMMs. An apparent PLD substrate specificity in transformed cells for phosphatidylcholine lacking arachidonate acyl groups is also explained by the localization of activity in the CEMMs where [(3)H]arachidonate-labeled PC was excluded. These data indicate that mitogenic signals through PLD are initiated in CEMMs where many signaling molecules colocalize. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873567     DOI: 10.1006/bbrc.2000.2907

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6.

Authors:  Lizhong Xu; Paul Frankel; Desmond Jackson; Thuy Rotunda; Rita L Boshans; Crislyn D'Souza-Schorey; David A Foster
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

2.  A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.

Authors:  Karen M Henkels; Hong-Juan Peng; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

Review 3.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

Review 4.  Phospholipase C and D regulation of Src, calcium release and membrane fusion during Xenopus laevis development.

Authors:  Bradley J Stith
Journal:  Dev Biol       Date:  2015-03-05       Impact factor: 3.582

5.  Role for phospholipase D in receptor-mediated endocytosis.

Authors:  Y Shen; L Xu; D A Foster
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

6.  Polyphosphoinositides are enriched in plant membrane rafts and form microdomains in the plasma membrane.

Authors:  Fabienne Furt; Sabine König; Jean-Jacques Bessoule; Françoise Sargueil; Rémi Zallot; Thomas Stanislas; Elodie Noirot; Jeanine Lherminier; Françoise Simon-Plas; Ingo Heilmann; Sébastien Mongrand
Journal:  Plant Physiol       Date:  2010-02-24       Impact factor: 8.340

7.  Paxillin phosphorylation and complexing with Erk and FAK are regulated by PLD activity in MDA-MB-231 cells.

Authors:  Jelena Pribic; Derrick Brazill
Journal:  Cell Signal       Date:  2012-03-28       Impact factor: 4.315

8.  PLD2 has both enzymatic and cell proliferation-inducing capabilities, that are differentially regulated by phosphorylation and dephosphorylation.

Authors:  Karen M Henkels; Stephen Short; Hong-Juan Peng; Mauricio Di Fulvio; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

9.  Phospholipase D2 Enhances Epidermal Growth Factor-Induced Akt Activation in EL4 Lymphoma Cells.

Authors:  Manpreet S Chahal; Daniel J Brauner; Kathryn E Meier
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-02

Review 10.  PLD3 in Alzheimer's disease.

Authors:  Jun Wang; Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.